BOBBY W. SANDAGE, JR., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2017-04-26 Dr. Sandage was appointed as a member of our Board of Directors on October 25, 2016. He serves on the Audit Committee, Compensation Committee, and Nominating and Governance Committee. Director compensation table shows $58,868 total compensation.
2018-05-07 The Audit Committee consists of Dr. Sandage (Chairman), Dr. Pedder and Mr. Reynolds. The Compensation Committee consists of Dr. Pedder (Chairperson), Mr. Reynolds and Dr. Sandage. The Nominating and Governance Committee consists of Mr. Reynolds (Chairman), Dr. Pedder and Dr. Sandage. Director compensation table shows Bobby W. Sandage, Jr., Ph.D. received $80,317 in 2017.

Data sourced from SEC filings. Last updated: 2026-02-03